Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Cilostazol |
Is a |
False |
agent antiplaquettaire |
Inferred relationship |
Some |
|
Anagrelide (substance) |
Is a |
False |
agent antiplaquettaire |
Inferred relationship |
Some |
|
Treprostinil sodium (substance) |
Is a |
False |
agent antiplaquettaire |
Inferred relationship |
Some |
|
Ticlopidine (substance) |
Is a |
False |
agent antiplaquettaire |
Inferred relationship |
Some |
|
Clopidogrel (substance) |
Is a |
False |
agent antiplaquettaire |
Inferred relationship |
Some |
|
Tirofiban (substance) |
Is a |
False |
agent antiplaquettaire |
Inferred relationship |
Some |
|
Eptifibatide (substance) |
Is a |
False |
agent antiplaquettaire |
Inferred relationship |
Some |
|
Dipyridamole (substance) |
Is a |
False |
agent antiplaquettaire |
Inferred relationship |
Some |
|
Iloprost (substance) |
Is a |
False |
agent antiplaquettaire |
Inferred relationship |
Some |
|
Médicament antiagrégant plaquettaire |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent antiplaquettaire |
Inferred relationship |
Some |
|
Product containing aspirin and isosorbide mononitrate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent antiplaquettaire |
Inferred relationship |
Some |
|
Isosorbide mononitrate+aspirin 60mg/150mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent antiplaquettaire |
Inferred relationship |
Some |
|
Isosorbide mononitrate+aspirin 60mg/75mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent antiplaquettaire |
Inferred relationship |
Some |
|
Antiplatelet aspirin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent antiplaquettaire |
Inferred relationship |
Some |
|
Product containing precisely aspirin 75 milligram/1 each conventional release orodispersible tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent antiplaquettaire |
Inferred relationship |
Some |
|
Aspirin 75 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent antiplaquettaire |
Inferred relationship |
Some |
|
Product containing precisely aspirin 75 milligram/1 each gastro-resistant oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent antiplaquettaire |
Inferred relationship |
Some |
|
Aspirin 75mg soluble tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent antiplaquettaire |
Inferred relationship |
Some |
|
Aspirin 300 mg gastro-resistant oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent antiplaquettaire |
Inferred relationship |
Some |
|
Anti-platelet prophylaxis |
Direct substance |
False |
agent antiplaquettaire |
Inferred relationship |
Some |
1 |
Resveratrol |
Is a |
False |
agent antiplaquettaire |
Inferred relationship |
Some |
|
[X]Antithrombotic drugs [platelet-aggregation inhibitors] causing adverse effects in therapeutic use |
Causative agent (attribute) |
False |
agent antiplaquettaire |
Inferred relationship |
Some |
|
Adverse reaction caused by antiplatelet agent |
Causative agent (attribute) |
False |
agent antiplaquettaire |
Inferred relationship |
Some |
1 |
Aspirin (substance) |
Is a |
False |
agent antiplaquettaire |
Inferred relationship |
Some |
|
Gastric ulcer caused by anti-platelet agent |
Causative agent (attribute) |
False |
agent antiplaquettaire |
Inferred relationship |
Some |
|
Duodenal ulcer caused by anti-platelet agent |
Causative agent (attribute) |
False |
agent antiplaquettaire |
Inferred relationship |
Some |
|
Antiplatelet agent therapy |
Direct substance |
False |
agent antiplaquettaire |
Inferred relationship |
Some |
1 |
Prasugrel (substance) |
Is a |
False |
agent antiplaquettaire |
Inferred relationship |
Some |
|
Anti-platelet prophylaxis |
Direct substance |
False |
agent antiplaquettaire |
Inferred relationship |
Some |
1 |
Antiplatelet agent therapy |
Direct substance |
False |
agent antiplaquettaire |
Inferred relationship |
Some |
1 |
Ticagrelor (substance) |
Is a |
False |
agent antiplaquettaire |
Inferred relationship |
Some |
|
Triflusal |
Is a |
False |
agent antiplaquettaire |
Inferred relationship |
Some |
|
Vorapaxar (substance) |
Is a |
False |
agent antiplaquettaire |
Inferred relationship |
Some |
|
Product containing treprostinil (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent antiplaquettaire |
Inferred relationship |
Some |
|
Treprostinil 600 microgram/mL solution for inhalation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent antiplaquettaire |
Inferred relationship |
Some |
|
Cangrelor (substance) |
Is a |
False |
agent antiplaquettaire |
Inferred relationship |
Some |
|
Indobufen (substance) |
Is a |
False |
agent antiplaquettaire |
Inferred relationship |
Some |
|
Treprostinil (substance) |
Is a |
False |
agent antiplaquettaire |
Inferred relationship |
Some |
|
Buffered aspirin (substance) |
Is a |
False |
agent antiplaquettaire |
Inferred relationship |
Some |
|
Ticlopidine hydrochloride (substance) |
Is a |
False |
agent antiplaquettaire |
Inferred relationship |
Some |
|
Clopidogrel besylate |
Is a |
False |
agent antiplaquettaire |
Inferred relationship |
Some |
|
Aluminum aspirin |
Is a |
False |
agent antiplaquettaire |
Inferred relationship |
Some |
|
Aloxiprin (substance) |
Is a |
False |
agent antiplaquettaire |
Inferred relationship |
Some |
|
Aspirin DL-lysine (substance) |
Is a |
False |
agent antiplaquettaire |
Inferred relationship |
Some |
|
Clopidogrel hydrochloride (substance) |
Is a |
False |
agent antiplaquettaire |
Inferred relationship |
Some |
|
Clopidogrel bisulfate (substance) |
Is a |
False |
agent antiplaquettaire |
Inferred relationship |
Some |
|
Tirofiban hydrochloride monohydrate (substance) |
Is a |
False |
agent antiplaquettaire |
Inferred relationship |
Some |
|
Anagrelide hydrochloride |
Is a |
False |
agent antiplaquettaire |
Inferred relationship |
Some |
|
Prasugrel hydrochloride (substance) |
Is a |
False |
agent antiplaquettaire |
Inferred relationship |
Some |
|
Gastric ulcer caused by anti-platelet agent |
Causative agent (attribute) |
False |
agent antiplaquettaire |
Inferred relationship |
Some |
1 |
Duodenal ulcer caused by anti-platelet agent |
Causative agent (attribute) |
False |
agent antiplaquettaire |
Inferred relationship |
Some |
1 |